Trumenba (meningococcal group B vaccine)

**Product type:** Vaccine

**Active ingredient:** NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN

**Strength:** 60; 60 ug/.5mL; ug/.5mL

**Dosage form:** Injection, Suspension

**Route:** Intramuscular

**Labeler:** Wyeth Pharmaceutical Division of Wyeth Holdings LLC

**Marketing category:** BLA (BLA125549)